Preoperative  ||| S:0 E:13 ||| JJ
CT-based  ||| S:13 E:22 ||| JJ
nomogram  ||| S:22 E:31 ||| NN
for  ||| S:31 E:35 ||| IN
predicting  ||| S:35 E:46 ||| VBG
overall  ||| S:46 E:54 ||| JJ
survival  ||| S:54 E:63 ||| NN
in  ||| S:63 E:66 ||| IN
women  ||| S:66 E:72 ||| NNS
with  ||| S:72 E:77 ||| IN
non-endometrioid  ||| S:77 E:94 ||| JJ
carcinomas  ||| S:94 E:105 ||| NN
of  ||| S:105 E:108 ||| IN
the  ||| S:108 E:112 ||| DT
uterine  ||| S:112 E:120 ||| JJ
corpus  ||| S:120 E:127 ||| NN
To  ||| S:127 E:130 ||| TO
develop  ||| S:130 E:138 ||| VB
a  ||| S:138 E:140 ||| DT
preoperative  ||| S:140 E:153 ||| JJ
CT-based  ||| S:153 E:162 ||| JJ
nomogram  ||| S:162 E:171 ||| NN
for  ||| S:171 E:175 ||| IN
predicting  ||| S:175 E:186 ||| VBG
overall  ||| S:186 E:194 ||| JJ
survival  ||| S:194 E:203 ||| NN
( ||| S:203 E:204 ||| -LRB-
OS ||| S:204 E:206 ||| NNP
)  ||| S:206 E:208 ||| -RRB-
in  ||| S:208 E:211 ||| IN
patients  ||| S:211 E:220 ||| NNS
with  ||| S:220 E:225 ||| IN
non-endometrioid  ||| S:225 E:242 ||| JJ
carcinomas  ||| S:242 E:253 ||| NN
of  ||| S:253 E:256 ||| IN
the  ||| S:256 E:260 ||| DT
uterine  ||| S:260 E:268 ||| JJ
corpus ||| S:268 E:274 ||| NN
.  ||| S:274 E:276 ||| .
Waiving  ||| S:276 E:284 ||| VBG
informed  ||| S:284 E:293 ||| JJ
consent ||| S:293 E:300 ||| NN
,  ||| S:300 E:302 ||| ,
the  ||| S:302 E:306 ||| DT
institutional  ||| S:306 E:320 ||| JJ
review  ||| S:320 E:327 ||| NN
board  ||| S:327 E:333 ||| NN
approved  ||| S:333 E:342 ||| VBD
this  ||| S:342 E:347 ||| DT
HIPAA-compliant ||| S:347 E:362 ||| JJ
,  ||| S:362 E:364 ||| ,
retrospective  ||| S:364 E:378 ||| JJ
study  ||| S:378 E:384 ||| NN
of  ||| S:384 E:387 ||| IN
193  ||| S:387 E:391 ||| CD
women  ||| S:391 E:397 ||| NNS
with  ||| S:397 E:402 ||| IN
histopathologically  ||| S:402 E:422 ||| FW
proven  ||| S:422 E:429 ||| FW
uterine  ||| S:429 E:437 ||| FW
papillary  ||| S:437 E:447 ||| FW
serous  ||| S:447 E:454 ||| FW
carcinomas  ||| S:454 E:465 ||| FW
( ||| S:465 E:466 ||| -LRB-
UPSC ||| S:466 E:470 ||| NNP
) ||| S:470 E:471 ||| -RRB-
,  ||| S:471 E:473 ||| ,
uterine  ||| S:473 E:481 ||| JJ
clear  ||| S:481 E:487 ||| JJ
cell  ||| S:487 E:492 ||| NN
carcinomas  ||| S:492 E:503 ||| NNS
( ||| S:503 E:504 ||| -LRB-
UCCC ||| S:504 E:508 ||| NNP
) ||| S:508 E:509 ||| -RRB-
,  ||| S:509 E:511 ||| ,
and  ||| S:511 E:515 ||| CC
uterine  ||| S:515 E:523 ||| JJ
carcinosarcomas  ||| S:523 E:539 ||| NNS
( ||| S:539 E:540 ||| -LRB-
UCS ||| S:540 E:543 ||| NNP
)  ||| S:543 E:545 ||| -RRB-
who  ||| S:545 E:549 ||| WP
underwent  ||| S:549 E:559 ||| VBD
primary  ||| S:559 E:567 ||| JJ
surgical  ||| S:567 E:576 ||| JJ
resection  ||| S:576 E:586 ||| NN
between  ||| S:586 E:594 ||| IN
May  ||| S:594 E:598 ||| NNP
1998  ||| S:598 E:603 ||| CD
and  ||| S:603 E:607 ||| CC
December  ||| S:607 E:616 ||| NNP
2011 ||| S:616 E:620 ||| CD
,  ||| S:620 E:622 ||| ,
and  ||| S:622 E:626 ||| CC
had  ||| S:626 E:630 ||| VBD
a  ||| S:630 E:632 ||| DT
preoperative  ||| S:632 E:645 ||| JJ
CT  ||| S:645 E:648 ||| NNP
≤  ||| S:648 E:650 ||| CD
6  ||| S:650 E:652 ||| CD
weeks  ||| S:652 E:658 ||| NNS
before  ||| S:658 E:665 ||| IN
surgery ||| S:665 E:672 ||| NN
.  ||| S:672 E:674 ||| .
All  ||| S:674 E:678 ||| DT
CT  ||| S:678 E:681 ||| NNP
scans  ||| S:681 E:687 ||| NNS
were  ||| S:687 E:692 ||| VBD
reviewed  ||| S:692 E:701 ||| VBN
for  ||| S:701 E:705 ||| IN
local  ||| S:705 E:711 ||| JJ
or ||| S:711 E:713 ||| CC
/ ||| S:713 E:714 ||| NNP
and  ||| S:714 E:718 ||| CC
regional  ||| S:718 E:727 ||| JJ
tumor  ||| S:727 E:733 ||| NN
extent ||| S:733 E:739 ||| NN
,  ||| S:739 E:741 ||| ,
presence  ||| S:741 E:750 ||| NN
of  ||| S:750 E:753 ||| IN
pelvic  ||| S:753 E:760 ||| JJ
or ||| S:760 E:762 ||| CC
/ ||| S:762 E:763 ||| NNP
and  ||| S:763 E:767 ||| CC
para-aortic  ||| S:767 E:779 ||| JJ
adenopathy ||| S:779 E:789 ||| NN
,  ||| S:789 E:791 ||| ,
and  ||| S:791 E:795 ||| CC
presence  ||| S:795 E:804 ||| NN
of  ||| S:804 E:807 ||| IN
distant  ||| S:807 E:815 ||| JJ
metastases ||| S:815 E:825 ||| NN
.  ||| S:825 E:827 ||| .
Univariate  ||| S:827 E:838 ||| JJ
survival  ||| S:838 E:847 ||| NN
analysis  ||| S:847 E:856 ||| NN
was  ||| S:856 E:860 ||| VBD
performed  ||| S:860 E:870 ||| VBN
using  ||| S:870 E:876 ||| VBG
log-rank  ||| S:876 E:885 ||| JJ
test  ||| S:885 E:890 ||| NN
and  ||| S:890 E:894 ||| CC
Cox  ||| S:894 E:898 ||| NNP
regression ||| S:898 E:908 ||| NN
.  ||| S:908 E:910 ||| .
Variables  ||| S:910 E:920 ||| NNS
shown  ||| S:920 E:926 ||| VBN
significant  ||| S:926 E:938 ||| JJ
by  ||| S:938 E:941 ||| IN
the  ||| S:941 E:945 ||| DT
univariate  ||| S:945 E:956 ||| JJ
analysis  ||| S:956 E:965 ||| NN
were  ||| S:965 E:970 ||| VBD
evaluated  ||| S:970 E:980 ||| VBN
with  ||| S:980 E:985 ||| IN
the  ||| S:985 E:989 ||| DT
multivariable  ||| S:989 E:1003 ||| JJ
Cox  ||| S:1003 E:1007 ||| NNP
regression  ||| S:1007 E:1018 ||| JJ
analysis  ||| S:1018 E:1027 ||| NN
and  ||| S:1027 E:1031 ||| CC
the  ||| S:1031 E:1035 ||| DT
results  ||| S:1035 E:1043 ||| NNS
were  ||| S:1043 E:1048 ||| VBD
used  ||| S:1048 E:1053 ||| VBN
to  ||| S:1053 E:1056 ||| TO
create  ||| S:1056 E:1063 ||| VB
a  ||| S:1063 E:1065 ||| DT
nomogram  ||| S:1065 E:1074 ||| NN
for  ||| S:1074 E:1078 ||| IN
predicting  ||| S:1078 E:1089 ||| VBG
OS ||| S:1089 E:1091 ||| NNP
.  ||| S:1091 E:1093 ||| .
The  ||| S:1093 E:1097 ||| DT
predictive  ||| S:1097 E:1108 ||| JJ
accuracy  ||| S:1108 E:1117 ||| NN
of  ||| S:1117 E:1120 ||| IN
the  ||| S:1120 E:1124 ||| DT
nomogram  ||| S:1124 E:1133 ||| NN
was  ||| S:1133 E:1137 ||| VBD
assessed  ||| S:1137 E:1146 ||| VBN
with  ||| S:1146 E:1151 ||| IN
the  ||| S:1151 E:1155 ||| DT
concordance  ||| S:1155 E:1167 ||| JJ
probability  ||| S:1167 E:1179 ||| NN
index  ||| S:1179 E:1185 ||| NN
( ||| S:1185 E:1186 ||| -LRB-
c-index ||| S:1186 E:1193 ||| NNP
)  ||| S:1193 E:1195 ||| -RRB-
and  ||| S:1195 E:1199 ||| CC
a  ||| S:1199 E:1201 ||| DT
3-year  ||| S:1201 E:1208 ||| JJ
calibration  ||| S:1208 E:1220 ||| JJ
plot ||| S:1220 E:1224 ||| NN
.  ||| S:1224 E:1226 ||| .
Mean  ||| S:1226 E:1231 ||| VB
patient  ||| S:1231 E:1239 ||| JJ
age  ||| S:1239 E:1243 ||| NN
was  ||| S:1243 E:1247 ||| VBD
67.2  ||| S:1247 E:1252 ||| CD
years  ||| S:1252 E:1258 ||| NNS
( ||| S:1258 E:1259 ||| -LRB-
range  ||| S:1259 E:1265 ||| NN
49.0-85.9 ||| S:1265 E:1274 ||| CD
) ||| S:1274 E:1275 ||| -RRB-
;  ||| S:1275 E:1277 ||| :
histologies  ||| S:1277 E:1289 ||| NNS
included  ||| S:1289 E:1298 ||| VBD
UPSC  ||| S:1298 E:1303 ||| NNP
( ||| S:1303 E:1304 ||| -LRB-
n  ||| S:1304 E:1306 ||| CD
=  ||| S:1306 E:1308 ||| SYM
116 ||| S:1308 E:1311 ||| CD
) ||| S:1311 E:1312 ||| -RRB-
,  ||| S:1312 E:1314 ||| ,
UCCC  ||| S:1314 E:1319 ||| NNP
( ||| S:1319 E:1320 ||| -LRB-
n  ||| S:1320 E:1322 ||| CD
=  ||| S:1322 E:1324 ||| SYM
27 ||| S:1324 E:1326 ||| CD
) ||| S:1326 E:1327 ||| -RRB-
,  ||| S:1327 E:1329 ||| ,
and  ||| S:1329 E:1333 ||| CC
UCS  ||| S:1333 E:1337 ||| NNP
( ||| S:1337 E:1338 ||| -LRB-
n  ||| S:1338 E:1340 ||| CD
=  ||| S:1340 E:1342 ||| SYM
50 ||| S:1342 E:1344 ||| CD
) ||| S:1344 E:1345 ||| -RRB-
.  ||| S:1345 E:1347 ||| .
Median  ||| S:1347 E:1354 ||| JJ
follow-up  ||| S:1354 E:1364 ||| NN
was  ||| S:1364 E:1368 ||| VBD
38.1  ||| S:1368 E:1373 ||| CD
months  ||| S:1373 E:1380 ||| NNS
( ||| S:1380 E:1381 ||| -LRB-
0.9-168.5  ||| S:1381 E:1391 ||| CD
months ||| S:1391 E:1397 ||| NNS
) ||| S:1397 E:1398 ||| -RRB-
.  ||| S:1398 E:1400 ||| .
At  ||| S:1400 E:1403 ||| IN
multivariate  ||| S:1403 E:1416 ||| JJ
analysis ||| S:1416 E:1424 ||| NN
,  ||| S:1424 E:1426 ||| ,
patient  ||| S:1426 E:1434 ||| JJ
age ||| S:1434 E:1437 ||| NN
,  ||| S:1437 E:1439 ||| ,
ascites ||| S:1439 E:1446 ||| NN
,  ||| S:1446 E:1448 ||| ,
and  ||| S:1448 E:1452 ||| CC
omental  ||| S:1452 E:1460 ||| JJ
implants  ||| S:1460 E:1469 ||| NN
on  ||| S:1469 E:1472 ||| IN
CT  ||| S:1472 E:1475 ||| NNP
were  ||| S:1475 E:1480 ||| VBD
significant  ||| S:1480 E:1492 ||| JJ
adverse  ||| S:1492 E:1500 ||| JJ
predictors  ||| S:1500 E:1511 ||| NN
of  ||| S:1511 E:1514 ||| IN
OS  ||| S:1514 E:1517 ||| NNP
and  ||| S:1517 E:1521 ||| CC
were  ||| S:1521 E:1526 ||| VBD
used  ||| S:1526 E:1531 ||| VBN
to  ||| S:1531 E:1534 ||| TO
build  ||| S:1534 E:1540 ||| VB
the  ||| S:1540 E:1544 ||| DT
nomogram ||| S:1544 E:1552 ||| NN
.  ||| S:1552 E:1554 ||| .
Concordance  ||| S:1554 E:1566 ||| JJ
index  ||| S:1566 E:1572 ||| NN
for  ||| S:1572 E:1576 ||| IN
the  ||| S:1576 E:1580 ||| DT
nomogram  ||| S:1580 E:1589 ||| NN
was  ||| S:1589 E:1593 ||| VBD
0.640  ||| S:1593 E:1599 ||| CD
±  ||| S:1599 E:1601 ||| CD
0.028 ||| S:1601 E:1606 ||| CD
.  ||| S:1606 E:1608 ||| .
We  ||| S:1608 E:1611 ||| PRP
developed  ||| S:1611 E:1621 ||| VBD
a  ||| S:1621 E:1623 ||| DT
nomogram  ||| S:1623 E:1632 ||| NN
with  ||| S:1632 E:1637 ||| IN
a  ||| S:1637 E:1639 ||| DT
good  ||| S:1639 E:1644 ||| JJ
concordance  ||| S:1644 E:1656 ||| JJ
probability  ||| S:1656 E:1668 ||| NN
at  ||| S:1668 E:1671 ||| IN
predicting  ||| S:1671 E:1682 ||| VBG
OS  ||| S:1682 E:1685 ||| NNS
based  ||| S:1685 E:1691 ||| VBN
on  ||| S:1691 E:1694 ||| IN
readily  ||| S:1694 E:1702 ||| RB
available  ||| S:1702 E:1712 ||| JJ
pretreatment  ||| S:1712 E:1725 ||| JJ
clinical  ||| S:1725 E:1734 ||| JJ
and  ||| S:1734 E:1738 ||| CC
imaging  ||| S:1738 E:1746 ||| JJ
characteristics ||| S:1746 E:1761 ||| NNS
.  ||| S:1761 E:1763 ||| .
This  ||| S:1763 E:1768 ||| DT
preoperative  ||| S:1768 E:1781 ||| JJ
nomogram  ||| S:1781 E:1790 ||| NN
has  ||| S:1790 E:1794 ||| VBZ
the  ||| S:1794 E:1798 ||| DT
potential  ||| S:1798 E:1808 ||| JJ
to  ||| S:1808 E:1811 ||| TO
improve  ||| S:1811 E:1819 ||| VB
initial  ||| S:1819 E:1827 ||| JJ
treatment  ||| S:1827 E:1837 ||| NN
planning  ||| S:1837 E:1846 ||| NN
and  ||| S:1846 E:1850 ||| CC
patient  ||| S:1850 E:1858 ||| JJ
counseling ||| S:1858 E:1868 ||| NN
.  ||| S:1868 E:1870 ||| .
